Erysipelas. Current concepts;Erysipele. Donnees recentes et questions d'actualite

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 9, 1996, Pages 585-593

  Petit, A ^a  

^a CENTRE HOSPITALIER VICTOR DUPOUY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PENICILLIN G;

DIFFERENTIAL DIAGNOSIS; ERYSIPELAS; HUMAN; REVIEW; STREPTOCOCCUS PYOGENES;

ERYSIPELAS; HUMANS;

EID: 0029836136     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Weinberg AN, Swartz MN. Bacterial diseases with cutaneous involvement. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine. New York: McGraw-Hill, 4th ed., 1993:2297-309.
2. Highet AS, Hay RJ, Roberts SOB. Cellulitis and erysipelas. In: Champion RH, Burton JL, Eblings FJG, eds. Rook-Wilkinson Ebling: Textbook of Dermatology. Oxford: Blackwell Scientific Pulications, 5th ed., 1992:968-73.
3. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996;334:240-245.
4. Bernard P, Bedane C, Mounier M, Denis F, Bonnetblanc JM. Dermohypodermite bactérienne de l'adulte. Incidence et place de l'étiologie streptococcique. Ann Dermatol Venereol 1995;122: 495-500.
5. Pour une évolution de la terminologie dermatologique en langue française. Ann Dermatol Venereol 1994;121:207-25.
6. Grosshans E. The red faces: erysipelas. Clin Dermatol 1993;11: 307-13.
7. Chartier C, Grosshans E. Erysipelas. Im J Dermatol 1990;29: 459-67.
8. Ronnen M, Suster S, Schewach-Millet M, Modan M, Erysipelas: changing faces. Int J Dermatol 1985;24:169-72.
9. Jorup-Ronstrom C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis 1986;18:519-24.
10. Bernard P, Bedane C, Mounier M, Denis F, Catanzano G. Bonnetblanc JM. Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol 1989;125:779-82.
11. Leppard BJ, Seal DV, Colman G, Hallas G. The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas. Br J Dermatol 1985;112:559-67.
12. Crickx B, Chevron F, Sigal-Nahum M, Bilet S, Faucher F, Picard C et al. Érysipèle : données épidémiologiques, cliniques et thérapeutiques (111 observations). Ann Dermatol Venereol 1991; 118:11-16.
13. Swartz MN. Erysipelas, cellulitis. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases. New York: John Wiley & Sons, 3th ed., 1991:800.
14. Hook EW. Acute cellulitis (Editorial). Arch Dermatol 1987; 123:460-1.
15. Mainetti C, Bernard P, Saurat JH. Hip surgery skin cellulitis. Eur J Med 1992;1:52-4.
16. Merot Y, Frenk E. Érysipèle et dermo-hypodermites infectieuses. In: Dubertret L, ed. Thérapeutique dermatologique. Paris: Flammarion, 1991:177-9.
17. Leyden JJ. Cellulitis (Editorial). Arch Dermatol 1989;125:823-4.
18. Mahé A, Destelle JM, Bruet A, Mathé C, Tuot D, Taveau JF et al. Thromboses veineuses profondes au cours des érysipèles de jambe. Étude prospective de 40 observations. Presse Med 1992;21:1022-4.
19. Perrot S, Perrot JL, Conchonnet P, Michel JL, Bertrand C, Lanthier K et al. Incidence des thromboses veineuses profondes des membres inférieurs au décours des érysipèles et cellulites de jambe. Étude prospective à propos de 86 malades (abstract). Ann Dermatol Venereol 1995;122(suppl 1):S117-8.
20. Bernard P, Plantin P, Roger H, Sassolas B, Villaret E, Legrain V et al. Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study. Br J Dermatol 1992;127:155-9.
21. Keefe M, Wakeel RA, Kerr REI. Erysipelas complicating chronic discoïd lupus erythematous of the face: a case report and review of erysipelas. Clin Exp Dermatol 1989;74:75-8.
22. Jorup-Ronstrom C, Britton S. Recurrent erysipelas: predisposing factors and costs of prophylaxis. Infection 1987;15:105-106.
23. Mortimer PS. Managing lymphoedema. Clin Exp Dermatol 1995;20:98-106.
24. Dan M, Heller K, Shapira I, Vidne B, Shibolet S. Incidence of erysipelas following venectomy for coronary artery bypass surgery. Infection 1987;15:107-8.
25. Shama S, Calandra GB. Atypical erysipelas caused by group G streptococci in a patient with cured Hodgkin's disease. Arch Dermatol 1982;118:934-6.
26. Saiag P, Goettmann S, Husson C, Roujeau JC, Revuz J, Touraine R. Érysipèle cervical récidivant survenant en zone irradiée. Ann Dermatol Venereol 1989;116:849-50.
27. Sotto A, Bessis D, Dereure O, Guillot B, Guilhou JJ. Érysipèle récidivant survenant en zone irradiée. Sem Hop Paris 1993; 69:129-30.
28. Johnson CC, Tunkel AR. Viridans streptococci and group C and G streptococci. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. New-York: Churchill Livingstone, 4th ed., 1995:1845-61.
29. Baddour LM, Bisno AL. Non group A β-hemolytic streptococcal cellulitis: association with venous and lymphatic compromise. Am J Med 1985;79:155-9.
30. Nohlgard C, Bjorklind A, Hammar H. Group G streptococcal infection on a dermatological ward. Acta Derm Venereol (Stockh) 1992;72:128-30.
31. Edwards S, Morven S, Baker CJ. Streptococcus agalactiae (group B streptococcus). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. New York: Churchill Livingstone, 4th ed, 1995:1835-45.
32. Binnick AN, Klein RB, Baughman RD. Reccurent erysipelas caused by group B streptococcus organisms. Arch Dermatol 1980;116:798-9.
33. Duvanel T, Auckenthaler R, Rohner P, Harms M, Saurat JH. Quantitative cultures of biopsy specimens from cutaneous cellulits. Arch Intern Med 1989;149:293-6.
34. Newell PM, Norden CW. Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults. J Clin Microbiol 1988;26:401-4.
35. Lebre C, Chosidow O, Girard-Pipau F, Saiag P, Revuz J, Roujeau JC. Intérêt des ponctions sous-cutanées dans les « cellulites »infectieuses (abstract). Journées Dermatologiques de Paris 1993, Poster 92.
36. Hook EW, Houton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 1986;146:295-7.
37. Bisno AL. Non suppurative post-streptococcal sequelae: rheumatic fever and glomerulonephritis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. New York: Churchill Livingstone, 4th ed., 1995:1799-810.
38. Chevrot A, Kahn MF, Morvan G, Imagerie des partie molles de l'appareil locomoteur. Montpellier: Sauramps Medical, 1993:151-8.
39. Gueorguieva H, Chosidow O, Rahmouni A, Faivre JM, Rouvre P, Beida M et al. Imagerie par résonnance magnétique des cellulites infectieuses (abstract). Journées Dermatologiques de Paris 1992, C23.
40. Saiag P, Lebreton C, Pavlovic M, Fouchard N, Delzant G, Bigot JM. Magnetic resonance imaging in adults presenting with severe acute infectious cellulitis. Arch Dermatol 1994;130:1150-8.
41. Zittergruen M, Grose C. Magnetic resonance imaging for early diagnosis of necrotizing fasciitis. Pediatr Emerg Care 1993;9:26-8.
42. Horrevorts AM, Huysmans FT, Koopman RJ, Meis JF. Cellulitis as first clinical presentation of disseminated cryptococcosis in renal transplant recipients. Scand J Infect Dis 1994;26:623-6.
43. Beasley DJ, Amedee RG. Deep neck space infections. J La State Med Soc 1995;147:181-4.
44. Singh B. The management of sinogenic orbital complications. J Laryngol Otol 1995;109:300-3.
45. Ollivaud L, Ortoli JC, Saiag P, Lefrere MA, Margulis A, Micheli E et al. Éruption à type d'érysipèle avec hyperleucocytose et fièvre : un nouveau syndrome paranéoplasique au cours du mélanome? Ann Dermatol Venereol 1993;120:831-3.
46. Lindmaier A, Jurecka W. Zwei Fälle eines Erysipelas melanomatorum. Differential diagnose und Terminologie. Hautarzt 1990; 47:628-32.
47. Torri O, Labeille B, Lok C, Ruto F, Decagny B, Gontier MF et al. Cellulite faciale fébrile : tableau sévère et trompeur d'une dermatose aiguë neutrophilique au cours d'une leucémie myéloïde chronique (abstract). Journées Dermatologiques de Paris 1993, Poster 41.
48. Dompmartin A, Troussard X, Lorier E, Jacobs F, Reman O, Leroy D et al. Sweet syndrome associated with acute myelogenous leukemia. Atypical form simulating facial erysipelas. Int J Dermatol 1991;30:644-7.
49. Moller R. Gibt es ein Kompartment-Syndrom in der Dermatologie? Z Hautkr 1989;64:835-6.
50. Petit A, Sigal M, Merat R, Pepin E, Couffinhal JC. Pseudo-erysipelas due to acute anterior tibial compartment syndrome J Am Acad Dermatol 1996;34:521-2.
51. Le Corvaisier C, Joly P, Thomine E, Lardans L, Rzeznick JC, Briard JL et al. Dermohypodermites localisées récidivantes après pose de matériel prothétique (abstract). Ann Dermatol Venereol 1994;121(suppl):S60-1.
52. Thomas V, Bourgault-Villada I, Jullien D, Wolkenstein P, Revuz J. Érysipèle après prothèse articulaire : signe d'alarme d'infection de la prothèse? (abstract). Ann Dermatol Venereol 1995;122(suppl):S68-9.
53. Pappo I, Vromen A, Seror D, Udassin R. Spontaneous splenic rupture associated with facial erysipelas. Harefuah 1993;124: 410-1, 455.
54. Guslits B. Upper airway obstruction due to erysipelas. Intensive Care Med 1991;17:370-1.
55. Kolko A, Brevet F, Mougenot B, Pagniez D, Fleury D, Vanhille P. Néphrite interstitielle aiguë et infection streptococcique. Nephrologie 1994;15:17-20.
56. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991;325:783-93.
57. Devaster JM, Struelens MJ, Schoutens C, Thys JP, Serruys E. Érysipèle fulminant. Rev Med Brux 1992;13:367-70.
58. Ligtenberg G, Blankestijn PJ, Koomans HA. Erysipelas: not always innocent. Neth J Med 1993;43:179-82.
59. Lotem M, Tamir G, Loven D, David M, Hauben D. Multiple basal cell carcinomas of the leg after recurrent erysipelas and chronic lymphedema. J Am Acad Dermatol 1994;31:812-3.
60. Lapidoth M, Hodak E, Segal R, Sandbak M. Secondary milia following bullous erysipelas. Cutis 1994;54:403-4.
61. Jorup-Ronstrom C, Britton S, Gavlevik A, Gunnarson K, Redman AC. The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas. Infection 1984;12: 390-4.
62. Grayson ML, Silvers J, Turnidge J. Home intravenous antibiotic therapy. A safe and effective alternative to in patient care. Med J Aust 1995;162:249-53.
63. Poretz DM, HIAT study group. Treatment of skin and soft tissue infection utilizing an out patient parenteral drug delivery device. Am J Med 1994;97:23-7.
64. Sjoblom AC, Bruchfeld J, Eriksson P, Jorup-Ronstrom C, Karkkonen K, Malmborg AS et al. Skin concentrations of phenoxymethylpenicillin in patients with erysipelas. Infection 1992; 20:34-7.
65. Bernard P, Risse L, Bonnetblanc JM. Traitement des dermohypodermites aiguës bactériennes de l'adulte par pristinamycine : étude ouverte chez 42 malades. Ann Dermatol Venereol 1996; 123:16-20.
66. Michel MF, Van Leeuwen WB. Degree and stability of tolerance to penicillin in Streptococcus pyogenes. Eur J Clin Microbiol Infect Dis 1989;8:225-32.
67. Bernard P, Risse L, Mounier M, Bonnetblanc JM. Portage de Staphylococcus aureus : facteur de gravité de l'érysipèle? Ann Dermatol Venereol 1996;123:12-5.
68. Roujeau JC. Cellulites bactériennes. In: Dubertret L, ed. Therapeutique dermatologique. Paris: Flammarion, 1991:108-10.
69. Sachs MK. Cutaneous cellulitis (Editorial). Arch Dermatol 1991;127:493-6.
70. Chosidow O, Saiag P, Pinquier L, Bastuji-Garin S, Revuz J, Roujeau JC. Non steroidal anti-inflammatory drugs in cellulitis: a cautionary note (lettre). Arch Dermatol 1991;127:493-6.
71. Levina LD, Ambalov IM, Poliak AI, Aitkuluev NS, Kovalenko AP, Usatkin AV. Effect on indirect endolymphatic antibiotherapy on clinical and immunological indicators in patients with erysipelas of the lower extremities. Antibiot Khimiother (Russia) 1992;37:24-6.
72. Moulin G, Bonnefoy M. Érysipèle. Rev Prat 1988;38:655-60.
73. Hammar H, Sverdrup B, Borglund E, Bomback M. Coagulation and fibrinolytic systems during the course of erysipelas and necrotizing fasciitis and the effect of heparin. Acta Derm Venereol 1985;65:495-503.
74. Jeune R. Érysipèle : données épidémiologiques, cliniques et thérapeutiques (lettre). Ann Dermatol Venereol 1991;118: 545-6.
75. Thind P. Prophylactic antibiotics in recurrent erysipelas (lettre). Lancet 1985:986.
76. Bitnun S. Prophylactic antibiotics in recurrent erysipelas (lettre). Lancet 1985:345.
77. Duvanel T, Harms M, Merot Y, Saurat JH. Les récidives d'érysipèle et leur prévention par la benzathine-pénicilline (abstract). Ann Dermatol Venereol 1986;113:174-5.
78. Kremer M, Zuckerman R, Avraham Z, Raz P. Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections. J Infect 1991;22:37-40.
79. Sjoblom AC, Eriksson B, Jorup-Ronstrom C, Karkkonen K, Lindqvist M. Antibiotic prophylaxis in recurrent erysipelas. Infection 1993;.21:390-3.
80. Norrby A, Eriksson B, Norgren M, Jorup-Ronstrom C, Sjoblom AC, Karkkonen K et al. Virulence properties of erysipelas-associated group A streptococci. Eur J Clin Microbiol Infect Dis 1992;11:1136-43.
81. Haustein UF, Biella U, Tausch I, Knoll H. Die Behandlung des chronisch-rezidivierenden Erysipels mit Streptokokkenvakzine. Hautarzt 1989;40:215-21.